Pyracrimycin A is a metabolic product isolated from Streptomyces eridani n. sp. (ATGG21619) (Beretta, 1970) , possessing an in vitro activity against Gram-positive and Gram-negative bacteria1}. The product was recovered ._ . from the fermentation broth by extraction with n-butanol I Ji.^*\^°a nd obtained in a pure state by crystallization from metha-N (n ol.
(I) NH*
The structure of trans 3-(l-pyrrolin-2-yl)acrylamide (I) was assigned to pyracrimycin A on the basis of the chemical and physical properties and confirmed by the synthesis of the tetrahydro derivative III. Pyracrimycin A is a white crystalline substance, m. p. 215-216°G. The elemental analysis accounts for G7H10N2O(M. W. 138.17) confirmed by the M+ peak in the mass spectrum (Fig. 1) . The IR spectrum (Fig. 2) is consistent with the presence of a primary amide group, as indicated by the bands at 3250 and 3050cm"1 (j>n-h solid state) and 1670cm"1 broad (amide I and amide II), and of C=C or C=N groups, as indicated by the bands at 1620and 1590cm"1. The presence of a strong band at 972 cm"1 indicates that the C=Cdouble bond bears two hydrogens in position trans. The PMRspectrum in DMSO-d6 (Fig. 3) shows the presence of the sequence -GH2-CH2-GH2-carrying at both sides heteroatoms or unsaturated carbon atoms, in any case not bearing hydrogen atoms (two triplets at 8 2.67ppm and 3.90ppm and a multiplet at 1.87ppm; attribution confirmed by spin decoupling), of two trans hydrogens on a conjugated C=G 6.55ppm, clearly indicating that in the reduced product a GHgroup is adjacent to the latter hydrogen. This can derive only from the selective reduction of the N=C group of the moiety -N=C-CH=CH-. All the data reported account for structure I, which at this point can be assigned to pyracrimycin A. In order to confirm structure I pyracrimycin A was reduced to the tetrahydro- Concerning the products obtained from microorganisms, acrylamide moiety was found to be present in different metabolites, whereas the pyrroline nucleus was found almost exclusively in the J2 or^3 form9>10). Anyhow, no relationship could be established between pyracrimycin A and other antibiotics so far described.
Experimental
Melting points were determined in capillary tubes and are uncorrected. IR spectra were taken on a Perkin-Elmer Model157 spectrophotometer as nujol mulls or CHC13 solutions. UVspectra were recorded with a Unicam S. P. 800 spectrophotometer. PMRspectra were taken with a Varian A-60 (60 MHz) or with a Varian HA-100 (100 MHz) spectrometer in the solvents indicated (5~10 % w/v), with TMSas internal reference (8 0.00 ppm). The mass spectra were recorded with a Hitachi Perkin-Elmer RMU-6L spectrometer (single focus) at electron ionizing voltage 70 V. Analytical thin-layer chromatographic separations (TLC) were performed on Silicagel HF/UV254 to a distance of 10.0 cm. The spots were detected after spraying with 0.1N I2 solution followed by cone. H2SO4.
Isolation of pyracrimycin A (I). The product was isolated from cultures of S. eridani as described1).
Dihydropyracrimycin A (II). To a solution of I (0.5g) in dry ethanol (300 ml) cooled in ice-bath, NaBH4(0.25g) was added, the solution was kept at 4°C for 2 hours and at room temperature for 12 hours under gentle stirring.
The excess of NaBH4 was decomposed with 10% HC1, the ethanol was evaporated under reduced pressure after dilution with water. The residual aqueous solution, after alkalinization with 10 %Na2CO3,was repeatedly extracted with ethyl acetate. The extracts were dried and concentrated to dryness Tetrahydropyracrimycin A (III). A solution of I (0.5 g) in methanol (110 ml) was reduced at normal pressure and room temperature with H2 over PtO2 catalyst (0.15g) with an H2 consumption of 2 moles/mole. The solution, filtered from the catalyst, was evaporated to 3070-2200 (yOH and NH2+), 1700 {y0=0), 1600 (<?NH2+), 1200 (vC-O), 880 cm"1 (rPH).
3-(Pyrrolidm-2-yl)propionamide (HI).
To a suspension of 3-(pyrrolidin-2-yl)propionic acid hydrochloride (1 g) in anhydrous chloroform (20 ml) containing one drop of pyridine, thionyl chloride (5 ml) was added, maintaining the temperature at 5°C. The mixture was stirred for 2 hours at roomtemperature and then concentrated in vacuo. The residue was treated at 0°C with a saturated solution of gaseous ammonia in anhydrous chloroform (40 ml). After stirring for 30 minutes the precipitate was filtered off, and the filtrate was evaporated in vacuo at room temperature. 
